Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

39 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ilixadencel, a Cell-based Immune Primer, plus Sunitinib Versus Sunitinib Alone in Metastatic Renal Cell Carcinoma: A Randomized Phase 2 Study.
Lindskog M, Laurell A, Kjellman A, Melichar B, Rey PM, Zieliński H, Villacampa F, Bigot P, Zoltan B, Parikh O, Alba DV, Jellvert Å, Flaskó T, Gallardo E, Caparrós MJR, Purkalne G, Suenaert P, Karlsson-Parra A, Ljungberg B. Lindskog M, et al. Among authors: kjellman a. Eur Urol Open Sci. 2022 Apr 26;40:38-45. doi: 10.1016/j.euros.2022.03.012. eCollection 2022 Jun. Eur Urol Open Sci. 2022. PMID: 35638086 Free PMC article.
Survival advantage of upfront cytoreductive nephrectomy in patients with primary metastatic renal cell carcinoma compared with systemic and palliative treatments in a real-world setting.
Ljungberg B, Sundqvist P, Lindblad P, Kjellman A, Thorstenson A, Hellström M, Kröger Dahlin BI, Thomasson M, Harmenberg U, Lundstam S. Ljungberg B, et al. Among authors: kjellman a. Scand J Urol. 2020 Dec;54(6):487-492. doi: 10.1080/21681805.2020.1815833. Epub 2020 Sep 8. Scand J Urol. 2020. PMID: 32897123 Free article.
Surgical waiting times and all-cause mortality in patients with non-metastatic renal cell carcinoma.
Karlsson Rosenblad A, Sundqvist P, Harmenberg U, Hellström M, Hofmann F, Kjellman A, Kröger Dahlin BI, Lindblad P, Lindskog M, Lundstam S, Ljungberg B. Karlsson Rosenblad A, et al. Among authors: kjellman a. Scand J Urol. 2022 Oct-Dec;56(5-6):383-390. doi: 10.1080/21681805.2022.2107067. Epub 2022 Aug 18. Scand J Urol. 2022. PMID: 35983600 Free article.
Predictive characteristics for disease recurrence and overall survival in non-metastatic clinical T1 renal cell carcinoma - results from the National Swedish Kidney Cancer Register.
Almdalal T, Karlsson Rosenblad A, Hellström M, Kjellman A, Lindblad P, Lundstam S, Sundqvist P, Ljungberg B. Almdalal T, et al. Among authors: kjellman a. Scand J Urol. 2023 Feb-Dec;57(1-6):67-74. doi: 10.1080/21681805.2022.2154383. Epub 2022 Dec 15. Scand J Urol. 2023. PMID: 36520023 Free article.
Primary Retroperitoneal Lymph Node Dissection as Treatment for Low-volume Metastatic Seminoma in a Population-based Cohort: The Swedish Norwegian Testicular Cancer Group Experience.
Thor A, Negaard HFS, Grenabo Bergdahl A, Almås B, Melsen Larsen S, Lundgren PO, Gerdtsson A, Halvorsen D, Johannsdottir B, Jansson AK, Hellström M, Wahlqvist R, Langberg CW, Hedlund A, Akre O, Glimelius I, Ståhl O, Haugnes HS, Cohn-Cedermark G, Kjellman A, Tandstad T. Thor A, et al. Among authors: kjellman a. Eur Urol Open Sci. 2024 Jun 11;65:13-19. doi: 10.1016/j.euros.2024.05.006. eCollection 2024 Jul. Eur Urol Open Sci. 2024. PMID: 38966804 Free PMC article.
Apalutamide Treatment and Metastasis-free Survival in Prostate Cancer.
Smith MR, Saad F, Chowdhury S, Oudard S, Hadaschik BA, Graff JN, Olmos D, Mainwaring PN, Lee JY, Uemura H, Lopez-Gitlitz A, Trudel GC, Espina BM, Shu Y, Park YC, Rackoff WR, Yu MK, Small EJ; SPARTAN Investigators. Smith MR, et al. N Engl J Med. 2018 Apr 12;378(15):1408-1418. doi: 10.1056/NEJMoa1715546. Epub 2018 Feb 8. N Engl J Med. 2018. PMID: 29420164 Free article. Clinical Trial.
Surgical Complications in Postchemotherapy Retroperitoneal Lymph Node Dissection for Nonseminoma Germ Cell Tumour: A Population-based Study from the Swedish Norwegian Testicular Cancer Group.
Gerdtsson A, Håkansson U, Törnblom M, Jancke G, Negaard HFS, Glimelius I, Halvorsen D, Karlsdóttir Á, Haugnes HS, Andreassen KE, Larsen SM, Holmberg G, Wahlqvist R, Tandstad T, Cohn-Cedermark G, Ståhl O, Kjellman A. Gerdtsson A, et al. Among authors: kjellman a. Eur Urol Oncol. 2020 Jun;3(3):382-389. doi: 10.1016/j.euo.2019.08.002. Epub 2019 Sep 8. Eur Urol Oncol. 2020. PMID: 31506250
39 results